首页> Pediatric radiology> Defining the ultrasound longitudinal natural history of newly diagnosed pediatric small bowel Crohn disease treated with infliximab and infliximab-azathioprine combination therapy.

Defining the ultrasound longitudinal natural history of newly diagnosed pediatric small bowel Crohn disease treated with infliximab and infliximab-azathioprine combination therapy.

导出 OA

翻译打印收藏纠错

第一作者： Jonathan R,Dillman

第一单位： Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., ML5031, Cincinnati, OH, 45229-3039, USA. jonathan.dillman@cchmc.org.

作者： Jonathan R,Dillman ^[1] ; Soudabeh Fazeli,Dehkordy ^[2] ; Ethan A,Smith ^[2] ; Michael A,DiPietro ^[2] ; Ramon,Sanchez ^[2] ; Vera,DeMatos-Maillard ^[3] ; Jeremy,Adler ^[3] ; Bin,Zhang ^[4] ; Andrew T,Trout ^[5]

作者单位： Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., ML5031, Cincinnati, OH, 45229-3039, USA. jonathan.dillman@cchmc.org. ^[1] Department of Radiology, Section of Pediatric Radiology, C. S. Mott Children's Hospital, University of Michigan Health System, Ann Arbor, MI, USA. ^[2] Department of Pediatrics, Division of Gastroenterology, C. S. Mott Children's Hospital, University of Michigan Health System, Ann Arbor, MI, USA. ^[3] Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. ^[4] Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., ML5031, Cincinnati, OH, 45229-3039, USA. ^[5]

关键词 Anti-tumor necrosis factor-alpha Biologic therapy Children Crohn disease Infliximab Small bowel Ultrasound